American Society of Echocardiography (ASE) President Benjamin Byrd III, M.D., FASE, explains some of the recent trends and issues facing cardiac ultrasound. These trends include reimbursement issues, the rapid expansion of point-of-care ultrasound and the critical role played by the new sub-specialty of interventional ultrasound.
Recent Videos View all 656 items
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.
As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.
His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.
Related content:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
In DAIC's continuing Thought Leadership Series with Dr. Jeffrey Soble, a practicing cardiologist at Rush University Medical Group’s Cardiology Intensive Care Unit, and CEO of Ascend Cardiovascular, he addresses the practical realities of artificial intelligence in echocardiology, the primary challenges echocardiographers face that AI support, and where he sees cardiovascular technology headed in the next three years. You can watch the first segment, DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings, here.
Related content:
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
In this segment of our DAIC Thought Leadership Series, which features one-on-one conversations with cardiovascular leaders, we're talking with Dr. Jeffrey Soble. He serves both as a practicing cardiologist at Rush University Medical Group’s Cardiology Intensive Care Unit, and CEO of Ascend Cardiovascular. In this video he addresses some of the challenges related to collaborating in complex cardiology settings, and provides insight into ways telepresence and augmented reality can be used — from a clinical perspective, using a holistic approach to structured reporting.
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
A New Partnership for Growth
Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
Exciting New Features at HIMSS24
At HIMSS2024, with this new collaboration comes new features, including:
- A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
- The Government Connections Plaza, featuring the latest rundown from Washington;
- A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
- Hot topics will be featured on the exhibition Main Stage; and
- A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.
Related content:
Find more HIMSS24 conference coverage here
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Sponsored Videos View all 46 items
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it easy for users to interpret what they are seeing. The TrueVue feature enhances the sense of depth and space, producing images that appear natural and realistic to the human eye.
Watch the video to check out how TrueVue can help improve views of LAA and MV morphology.
Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to every echo exam. The AI-empowered algorithm delivers fast and consistent measurements – in half the time of manual methods.*
Watch the video to see how you can put “smart” to work with the latest AI-powered quantification tools.
*External study with external sonographers comparing the results of 18 exams with and without AutoMeasure
The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased array transducer. When combined with nSIGHT Plus image formation on the EPIQ CVx cardiology ultrasound system, the X5-1c transducer enables image quality rarely seen from a transthoracic transducer.
Watch the video to learn about the benefits which may include decreased exam time due to faster access to echo windows, increased confidence in quantification results and more.
Philips recently announced an update to their flagship EPIQ CVx premium cardiology ultrasound system. Watch the video to learn about the latest features including the next-generation nSIGHT Plus imaging architecture system that leverages both hardware and software to support sophisticated image formation and enhanced image quality.
Conference Coverage View all 467 items
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.
As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.
His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.
Related content:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
A New Partnership for Growth
Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
Exciting New Features at HIMSS24
At HIMSS2024, with this new collaboration comes new features, including:
- A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
- The Government Connections Plaza, featuring the latest rundown from Washington;
- A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
- Hot topics will be featured on the exhibition Main Stage; and
- A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.
Related content:
Find more HIMSS24 conference coverage here
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Health That Connects + Tech That Cares at HIMSS 2023
ACC22: Transforming Cardiovascular Care
Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Cath Lab View all 316 items
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.
As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.
His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.
Related content:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
A New Partnership for Growth
Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
Exciting New Features at HIMSS24
At HIMSS2024, with this new collaboration comes new features, including:
- A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
- The Government Connections Plaza, featuring the latest rundown from Washington;
- A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
- Hot topics will be featured on the exhibition Main Stage; and
- A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.
Related content:
Find more HIMSS24 conference coverage here
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Health That Connects + Tech That Cares at HIMSS 2023
ACC22: Transforming Cardiovascular Care
Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Cardiac Imaging View all 289 items
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.
As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.
His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.
Related content:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
A New Partnership for Growth
Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
Exciting New Features at HIMSS24
At HIMSS2024, with this new collaboration comes new features, including:
- A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
- The Government Connections Plaza, featuring the latest rundown from Washington;
- A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
- Hot topics will be featured on the exhibition Main Stage; and
- A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.
Related content:
Find more HIMSS24 conference coverage here
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Health That Connects + Tech That Cares at HIMSS 2023
ACC22: Transforming Cardiovascular Care
Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Cardiac Diagnostics View all 78 items
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.
As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.
His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.
Related content:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
A New Partnership for Growth
Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
Exciting New Features at HIMSS24
At HIMSS2024, with this new collaboration comes new features, including:
- A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
- The Government Connections Plaza, featuring the latest rundown from Washington;
- A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
- Hot topics will be featured on the exhibition Main Stage; and
- A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.
Related content:
Find more HIMSS24 conference coverage here
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Health That Connects + Tech That Cares at HIMSS 2023
ACC22: Transforming Cardiovascular Care
Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
EP Lab View all 83 items
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.
As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.
His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.
Related content:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
A New Partnership for Growth
Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
Exciting New Features at HIMSS24
At HIMSS2024, with this new collaboration comes new features, including:
- A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
- The Government Connections Plaza, featuring the latest rundown from Washington;
- A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
- Hot topics will be featured on the exhibition Main Stage; and
- A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.
Related content:
Find more HIMSS24 conference coverage here
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Health That Connects + Tech That Cares at HIMSS 2023
ACC22: Transforming Cardiovascular Care
Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Information Technology View all 177 items
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.
As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.
His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.
Related content:
DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology
DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings
Industry trade shows and conferences seem to be making their comeback in 2024. And the Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition seems particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare, but also the delivery of a quality experience for those in this demanding, rapidly evolving industry. This month in our ongoing One on One series with industry leaders, we are talking with Hal Wolf, FHIMSS, president and CEO of HIMSS. He offered insights on the society’s new partnership with Informa Markets, key topics being covered at HIMSS24, AI’s impact on the industry, and his thoughts on healthcare sustainability.
Find more HIMSS24 conference coverage here
A New Partnership for Growth
Last August, Informa Markets and HIMSS announced a landmark partnership to propel the growth and evolution of the HIMSS Global Health Conference and Exhibition, recognized as the most influential healthcare technology event of the year, and in North America. It draws 40,000 health professionals, tech leaders, providers and governmental organizations from across the globe. Informa Markets, the world’s largest exhibition organizer, took on management of the HIMSS Exhibition, while HIMSS continues to oversee developing expert content and programming.
Exciting New Features at HIMSS24
At HIMSS2024, with this new collaboration comes new features, including:
- A Digital Health Technology Theme Park, filled with innovations that revolve around AI, workforce and the business of healthcare;
- The Government Connections Plaza, featuring the latest rundown from Washington;
- A reimagined Interoperability Showcase for a deeper dive into the inner workings of healthcare;
- Hot topics will be featured on the exhibition Main Stage; and
- A Hosted Buyer Program, facilitating focused meetings between providers and trusted companies in healthcare technology.
Related content:
Find more HIMSS24 conference coverage here
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
HIMMS is working to bring empirical knowledge and evidence of value and impact of digital maturity measured by the HIMSS maturity models and the Digital Health Indicator (DHI), which is a blueprint for digital health advancement. The maturity models provide prescriptive frameworks to healthcare organizations to help build their digital health ecosystems. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about these models, and what the latest scientific research is telling us.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead
Health That Connects + Tech That Cares at HIMSS 2023
ACC22: Transforming Cardiovascular Care
Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this comes the need for transformation to keep up with these advancements. DAIC spoke with Anne Snowdon, RN, PhD, FAAN, professor of strategy entrepreneurship, Odette Business School, University of Windsor, CEO of SCAN Health and Chief Scientific Research Officer, HIMSS Analytics, to find out more about the steps needed for this transformation and what we can expect to see in the future of healthcare.
Dr. Anne Snowdon is a Professor of Strategy and Entrepreneurship at the Odette School of Business, University of Windsor. Currently, Dr. Snowdon is the Chief Scientific Research Officer for HIMSS, Vice Chair of the Board of the Directors for Alberta Innovates, and member of the Health Futures Council of Arizona State University (ASU). She is an Adjunct Faculty at the Department of Computer Science at the University of Windsor, the School of Nursing at Dalhousie University and the Centre for Innovative Medical Technology (CIMT), at the University of Southern Denmark. Dr. Snowdon is leading a national Community of Practice to advance supply chain resilience across Canada, she has published more than 150 research articles, papers and cases, has received over $24 million in research funding, holds patents and has commercialized a highly successful booster seat product for children traveling in vehicles and is a Fulbright Scholar. She holds a PhD in Nursing from the University of Michigan, an MSc from McGill University, and BScN from Western University.
Find more HIMSS23 coverage here
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
Related Digital Transformation Content:
Robocath Launches New Robotic Platform R-One+
VIDEO: Using Maturity Models to Measure Digital Health
VIDEO: Moving Digital Transformation Forward in Healthcare
VIDEO: Key Components to Creating and Implementing AI and Digital Transformation Solutions
VIDEO: The Benefits and Pitfalls of Artificial Intelligence in Healthcare
VIDEO: A Look at Cybersecurity and How Healthcare is at Risk
New ACC President Defines Priorities for Year Ahead